Tiger Brokers

HK StockDetailed Quotes
Provided by Tiger Fintech (Singapore) Pte. Ltd.

HUA MEDICINE-B

2.910
+0.0702.46%
Volume:8.05M
Turnover:23.00M
Market Cap:3.07B
PE:-10.43
High:2.930
Open:2.850
Low:2.760
Close:2.840
Loading ...
OverviewCompanyNewsFilings

Company Profile

Company Name:
HUA MEDICINE-B
Exchange:
SEHK
Establishment Date:
2011
Employees:
168
Office Location:
Hua Medicine, Building 2, Lane 36,Xuelin Road,Pudong New Area,Shanghai,China
Website:
http://www.huamedicine.com
Zip Code:
201203
Phone:
86 21 3810 1800
Fax:
86 21 3810 1808
Introduction:
Hua Medicine is a China-based company principally engaged in the drug development business. The Company is mainly engaged in the development of an oral drug, Dorzagliatin, or HMS5552, for the treatment of Type 2 diabetes. The Company mainly operates its business in the domestic and overseas markets.

Directors

Name
Position
Robert Taylor NELSEN
Chairman of the Board,Director,Member of the Strategic and Development Committee,Chairman of the Nomination Committee
CHEN Li
Executive Director,Chairman of the Strategic and Development Committee
LIN Jie Cheng
Executive Director,Member of the Strategic and Development Committee
ZHANG Yi
Executive Director
William Robert Keller
Independent Director,Chairman of the Remuneration and Assessment Committee,Member of the Nomination Committee,Audit Committee Member
TSUI Yiu Wa Alec
Independent Director,Member of the Remuneration and Assessment Committee,Member of the Nomination Committee,Audit Committee Member
ZHANG Yao Liang
Independent Director,Audit Committee Chairman

Shareholders

Name
Position
CHEN Li
CEO
DANIEL YUNLONG DU
Vice General Manager
ZHANG Yi
Vice General Manager
SHE Jin
Vice General Manager
FU Yi Lei
Vice General Manager
XU Wen Jie
Vice General Manager,Other Senior Executives
TANG Fu Xing
Vice General Manager,CTO,Other Senior Executives
YUAN Ying Xin
Corporate Secretary
LI Chang Hong
Chief Science Officer
LIN Jie Cheng
Other Senior Executives,Other Senior Executives
Franz M. MATSCHINSKY
Advisor